Olympus to cut 2,000 jobs in endoscopy reorganization

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

By Susan Kelly • Nov. 7, 2025

Health groups urge passage of bill to ease Medicare pay cuts for tests

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to stop looming Medicare payment cuts for diagnostic tests.

By Susan Kelly • Nov. 3, 2025

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

Turning aspirational innovations into tangible impacts

Making tomorrow’s breakthroughs a reality for the patients who need.

Nov. 3, 2025

Agilent selects Adam Elinoff as CFO

The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.

By Nick Paul Taylor • Oct. 31, 2025

Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it

Kelsey Mayo, CEO of Armor Medical, received the grand prize in MedTech Innovator’s pitch competition for a wearable technology to detect serious blood loss early.

By Elise Reuter • Oct. 23, 2025

Hologic to go private for up to $18.3B

Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.

By Elise Reuter • Oct. 21, 2025

AdvaMed calls for series of trade actions in response to Section 232 probe

In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.

By Susan Kelly • Oct. 20, 2025

BD CFO Chris DelOrefice leaving for new job

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.

By Susan Kelly • Oct. 16, 2025

Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout

The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, Kihealth raised $5 million in seed funding to launch its early detection test.

By Susan Kelly • Oct. 6, 2025

CDRH shares regulatory guidance priorities for the coming 12 months

Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.

By Nick Paul Taylor • Oct. 2, 2025

MedTech Europe pressures EU to make regulatory changes by early 2026

The request includes a call to postpone re-certification requirements for devices already certified under the medical technology regulations.

By Nick Paul Taylor • Sept. 26, 2025

Quest to distribute Guardant colon cancer blood test

Guardant Health Co-CEO AmirAli Talasaz also unveiled plans to launch the Shield test for multi-cancer detection in October.

By Susan Kelly • Sept. 25, 2025

Multi-cancer blood tests aren’t ready for routine use, review says

Research funded by the Agency for Healthcare Research and Quality found insufficient evidence to determine the accuracy — or possible harm — of the cancer screenings.

By Susan Kelly • Sept. 23, 2025

FDA rescinds LDT final rule

Regulation of lab developed tests returns to its status before the agency attempted to expand its jurisdiction and industry groups sued to stop it.

By Susan Kelly • Sept. 19, 2025

House committee advances Medicare coverage bill for breakthrough devices

AdvaMed welcomed the committee’s work on the legislation but called for the inclusion of diagnostics in the bill.

By Nick Paul Taylor • Sept. 18, 2025

New bill would reform lab test payment rates

The bipartisan legislation, introduced this week in the House and Senate, seeks to prevent more cuts to Medicare reimbursement rates for diagnostic tests.

By Susan Kelly • Sept. 12, 2025

Medtech VC funding on track to hit highest value since 2021: PitchBook

“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.

By Nick Paul Taylor • Sept. 2, 2025

Quest forms joint venture with Corewell Health

The diagnostics company will open a lab with Corewell Health in 2027 and manage the not-for-profit health system’s existing lab facilities.

By Nick Paul Taylor • Aug. 27, 2025

Tempus inks $81M Paige buyout to support AI model development

CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.

By Nick Paul Taylor • Aug. 26, 2025

US to maintain lower tariff rates on China imports for 90 more days

China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.

By Max Garland • Aug. 12, 2025

GE HealthCare projects reduced tariff expense

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.

By Susan Kelly • July 30, 2025

Quest, Labcorp downplay ‘Big Beautiful Bill’ impact

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.

By Susan Kelly • July 29, 2025

Labcorp to buy some Community Health assets for $195M

The deal includes outreach laboratory services in 13 states. Community Health will continue to operate its inpatient and emergency department labs along with other hospital-based testing services.

By Susan Kelly • July 24, 2025

Agilent CFO Bob McMahon resigns

Rodney Gonsalves, corporate controller and principal accounting officer, will take on interim CFO duties. Analysts said the company’s reaffirmed third-quarter guidance should reassure investors.

By Susan Kelly • July 17, 2025

Abbott lowers sales forecast on diagnostics decline, US funding cuts

Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

By Elise Reuter • July 17, 2025